FibroBiologics prices unregistered $3 million share private placement at $0.735 per share

FibroBiologics, Inc.

FibroBiologics, Inc.

FBLG

0.00
  • FibroBiologics priced an at-the-market private placement of 4,081,633 common shares or pre-funded warrants at USD 0.74 each.
  • Deal includes series A warrants for 4,081,633 shares, series B warrants for 4,081,633 shares; both struck at USD 0.74.
  • Gross proceeds expected at about USD 3 million; warrant exercise could add about USD 6 million, subject to stockholder approval.
  • Closing targeted around June 29, 2026; H.C. Wainwright serving as exclusive placement agent.
  • Net proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606260830PR_NEWS_USPR_____DA92986) on June 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.